CYDI Revenue third quarter 2014 Y/Y Growth Comment
Cybrdi, Inc. reported fall in Revenue in the third quarter 2014 by -13.9% to $ 0.11 millions, from the same quarter in 2013. The decline in the third quarter 2014 Cybrdi, Inc.'s Revenue compares unfavorably to the Company's average Revenue decrease of -0.1%.
Looking into third quarter 2014 results within Laboratory Analytical Instruments industry 21 other companies have achieved higher Revenue growth. While Cybrdi, Inc.' s Revenue decrease of -13.9% ranks overall at the positon no. 3502 in the third quarter 2014.
Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014
Cybrdi,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
132.04 %
3 %
-100 %
(Dec 31 2012)
CYDI's III. Quarter Q/Q Revenue Comment
Cybrdi, Inc. achieved in the III. Quarter 2014 above company average sequential Revenue jump of 24.37%, to $ 0.11 millions, from $0.09 millions in the second quarter. CYDI is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Cybrdi,'s Revenue growth quarter on quarter, overall rank is 563.
Cybrdi, Inc. achieved in the III. Quarter 2014 above company average sequential Revenue jump of 24.37%, to $ 0.11 millions, from $0.09 millions in the second quarter. CYDI is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Cybrdi,'s Revenue growth quarter on quarter, overall rank is 563.
Cybrdi,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Sep 30 2014)
12 Months Ending (Jun 30 2014)
12 Months Ending (Mar 31 2014)
12 Months Ending (Dec 31 2013)
12 Months Ending (Sep 30 2013)
Cumulative Revenue 12 Months Ending
$ 0.50
$ 0.52
$ 0.57
$ 0.57
$ 0.72
Y / Y Revenue Growth (TTM)
-31.08 %
-27.78 %
-17.35 %
-26.67 %
11.78 %
Year on Year Revenue Growth Overall
Ranking
# 2766
# 0
# 0
# 0
# 0
Seqeuential Revenue Change (TTM)
-4.05 %
-9.3 %
-0.41 %
-20.48 %
0.54 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2029
# 3267
# 0
# 0
# 0
Cumulative Revenue growth Comment
Cybrdi,'s cumulative 12 months Revenue continue to drop, but on the faster rate at -31.08% year on year, at Sep 30 2014 compare to the -27.78% decrease at Jun 30 2014. If the Cybrdi,'s fiscal year would end at Sep 30 2014, annual Revenue would be $1 millions.
In the Healthcare sector 290 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2766.
Cybrdi,'s cumulative 12 months Revenue continue to drop, but on the faster rate at -31.08% year on year, at Sep 30 2014 compare to the -27.78% decrease at Jun 30 2014. If the Cybrdi,'s fiscal year would end at Sep 30 2014, annual Revenue would be $1 millions.
In the Healthcare sector 290 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2766.
About Cybrdi, Revenue Growth Rates (CYDI), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
